Agenus has been working on cancer medicines for nearly three decades. The company was cofounded in 1994 and has been publicly traded since 2000. Over that time its churned through a variety of cancer drug approaches and established a lengthy list of partners among them Merck  Co Gilead Sciences and Bristol Myers Squibb 